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Validation of an Accelerometer to Quantify
a Comprehensive Battery of Gait Characteristics in
Healthy Older Adults and Parkinson’s Disease:
Toward Clinical and at Home Use
Silvia Del Din, Member, IEEE, Alan Godfrey, Member, IEEE, and Lynn Rochester
Abstract—Measurement of gait is becoming important as a tool
to identify disease and disease progression, yet to date its applica-
tion is limited largely to specialist centers. Wearable devices en-
ables gait to be measured in naturalistic environments, however
questions remain regarding validity. Previous research suggests
that when compared with a laboratory reference, measurement
accuracy is acceptable for mean but not variability or asymmetry
gait characteristics. Some fundamental reasons for this have been
presented, (e.g., synchronization, different sampling frequencies)
but to date this has not been systematically examined. The aims of
this study were to: 1) quantify a comprehensive range of gait char-
acteristics measured using a single triaxial accelerometer-based
monitor; 2) examine outcomes and monitor performance in mea-
suring gait in older adults and those with Parkinson’s disease (PD);
and 3) carry out a detailed comparison with those derived from an
instrumented walkway to account for any discrepancies. Fourteen
gait characteristics were quantified in 30 people with incident PD
and 30 healthy age-matched controls. Of the 14 gait characteris-
tics compared, agreement between instruments was excellent for
four (ICCs 0.913–0.983); moderate for four (ICCs 0.508–0.766);
and poor for six characteristics (ICCs 0.637–0.370). Further anal-
ysis revealed that differences reflect an increased sensitivity of ac-
celerometry to detect motion, rather than measurement error. This
is most likely because accelerometry measures gait as a continuous
activity rather than discrete footfall events, per instrumented tools.
The increased sensitivity shown for these characteristics will be of
particular interest to researchers keen to interpret “real-world”
gait data. In conclusion, use of a body-worn monitor is recom-
mended for the measurement of gait but is likely to yield more
sensitive data for asymmetry and variability features.
Index Terms—Accelerometer, algorithm, body-worn monitor,
instrumented gait, instrumented walkway.
I. INTRODUCTION
GAIT is emerging as a powerful tool in neurodegenerativedisease to identify surrogate markers of incipient disease
manifestation or disease progression [1]–[5].
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However, its widespread adoption for clinical and research
purposes has been limited to date. This is largely because the
majority of studies have been carried out using specialized gait
analysis equipment (most commonly instrumented walkways,
such as pressure-sensor activated, e.g., GaitRite) [6]–[9] which
limits the work to specialized centers and a sparse number of
gait cycles [10]. In order to develop the use of quantitative gait
analysis for clinical screening and research, low-cost tools are
required that facilitate measurement in the clinic and home.
This has driven an interest in the use of accelerometer-based
body-worn monitors (BWM) for measuring gait.
BWM can provide a continuous sampling of whole body
movement in controlled or habitual environments [11]. A BWM
worn on the lower back implementing single/numerous algo-
rithm(s) can provide a simple method to quantify gait; the adop-
tion of the inverted pendulum model to evaluate step length
and the use of appropriate filtering procedures to identify ini-
tial/final (IC/FC) contact events within the gait cycle [12]–[14].
However, it is essential to validate the combination of BMW and
implemented algorithms to accurately capture gait outcomes be-
fore widespread adoption. Evidence suggests suitable validity
and reliability of estimated mean values of gait outcomes to a
trusted laboratory reference (GaitRite) [12], [13], [15]–[19]. Yet
moderate to poor agreement has been reported for step-to-step
fluctuations (variability) and bilateral coordination (asymmetry)
[12], [14], [15], [17], [20]–[22]. This leaves the role of BWM to
comprehensively quantify gait in ageing and pathology unclear.
A comprehensive examination of systems is lacking within
the literature, which is critical to further understand and explain
the poor agreement for asymmetry and variability gait char-
acteristics. Previous studies have tried to provide a rationale
for the poor agreement, such as difference in sampling rates,
misalignment due to device orientation/placement, and poor
synchronization [12], [13], [15], [23]. However, questions still
remain. Furthermore, weaknesses of previous studies [12]–[15],
[21] include: 1) limited and inconsistent reporting of gait char-
acteristics [12]–[15]; 2) introduction of newly derived variables
[23]–[25], which are difficult to interpret making mainstream
use problematic; 3) restricted testing on a single (small) cohort
(ranging on average from 10 to 23 participants [12], [13], [15],
[20], [23]), often with a lack of consideration for the effects
of pathology on BWM performance; and 4) lack of BWM sig-
nal examination compared to video recordings. Evaluation of a
comprehensive set of gait characteristics is, therefore, needed
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while undertaking a systematic examination of all data acquired
during a validation-based study of a BWM.
The purpose of this study was, therefore, to take a systematic
approach to address gaps in the literature. First, we aimed to
characterize a broad range of gait characteristics using a low-
cost BWM in a large cohort of participants. While multiple
characteristics can describe gait, studies helped us to provide a
simplified framework for selection of important gait character-
istics [5], [26], [27]. In this study, characteristics were selected
based on our previous work [27], [28], which identified a com-
prehensive range of 16-core gait characteristics (using GaitRite)
recognized as an indicative of healthy ageing and pathology
(Parkinson’s disease, PD). Here, we used a BWM and adopted
a novel combination of two algorithms to quantify gait grouped
by the properties they measure, such as summary mean val-
ues, variability and asymmetry, and including phases of the gait
cycle. Second, we wanted to compare results in PD and older
adults to see if the performance of the BWM remained stable in
pathology. The adoption of two cohorts is a key feature of this
paper, providing contrasting features of gait, where asymmetric
and variability characteristics are known to differ. Finally, we
compared the findings from the BWM to a common laboratory
reference for comparability with previous work and where pos-
sible carried out a detailed evaluation, where differences were
found between systems in order to characterize the source of er-
ror. In adopting this process, we wished to determine the ability
of a low-cost BWM to accurately measure a comprehensive set
of core gait characteristics in normal and pathological condi-
tions for confidence in more widespread adoption. This forms a
part of our ongoing work to quantify gait simply and effectively
within laboratory-based instrumented testing sessions, with a
view to quantifying gait in real-world environments.
II. METHODS
A. Participants
Thirty PD patients within four months of diagnosis and 30
healthy aged matched control subjects (HC) were recruited from
the incidence of cognitive impairment in cohorts with longitudi-
nal evaluation-gait (ICICLE-GAIT) study. This is a collabora-
tive study with the incidence of cognitive impairment in cohorts
with longitudinal evaluation-PD (ICICLE-PD), an incident co-
hort study conducted between June 2009 and December 2011
[29]. This study was conducted according to the declaration of
Helsinki and had ethical approval from the Newcastle and North
Tyneside research ethics committee. All participants signed an
informed consent form prior to testing.
B. Demographic and Clinical Measures
Age, gender, and body mass index (BMI) were recorded for
each participant. Cognition was assessed with the Montreal
cognitive assessment (MoCA) [30]. Balance confidence was
measured using the self-rated activities balance self-confidence
scale [31]. The severity of PD motor symptoms in the PD par-
ticipants was measured using the Hoehn and Yahr scale [32],
which ranges from 0 (no symptoms) to 5 (wheelchair bound or
Fig. 1. Triaxial accelerometer-based device and site of attachment on the
lower back (L5) and laboratory set up for testing intermittent walks.
bedridden if unaided), and Section III of the modified movement
disorder society version of the unified Parkinson’s disease rat-
ing scale (MDS-UPDRS [33]), which ranges from 0 (no motor
symptoms) to 132 (severe motor symptoms). The postural insta-
bility and gait disorder (PIGD) and Tremor phenotype subscales
were also calculated from the MDS-UPDRS [34]. Levodopa
equivalent daily doses were calculated according to established
methods [35].
C. Equipment
Each participant was asked to wear a low-cost (<£100) tri-
axial accelerometer-based device (Axivity AX3, dimensions:
23.0× 32.5× 7.6 mm, weight: 9 g) located on the fifth lumbar
vertebrae (L5) (see Fig. 1). It is a generic movement monitor that
is nonspecific for gait or ambulatory assessment and was held in
place by double-sided tape (Wig Tape, Natural Image, U.K.) and
Hypafix (BSN Medical Limited, Hull, U.K.). The device mea-
sures vertical (av ), anteroposterior (aa ), and mediolateral (am )
accelerations and was programmed to capture data at 50 and
100 Hz (16-bit resolution) and at a range of±8 g. The change in
sampling frequency was due to upgrading of the device during
the longitudinal ICICLE-PD gait study, where updated versions
had increased memory and sampling capabilities. However, for
consistency of analysis, all data were downsampled, where nec-
essary, to 50 Hz.
Gait assessment was conducted concurrently as a part of the
ICICLE-GAIT study using a 7.0-m long × 0.6-m wide instru-
mented walkway (Platinum model GaitRite, software version
4.5, CIR systems, NJ, USA), which was synchronized with a
video camera (Logitech, Webcam Pro 9000, CA, USA) record-
ing at 25 Hz. The instrumented walkway had a spatial accuracy
of 1.27 cm and temporal accuracy of one sample (240 Hz,
∼4.17 ms).
The quartz-stabilized real-time clock of the accelerometer
(accuracy: 20 ppm) was synchronized with the computer used
for the walkway recordings, and for each walking trial, the
start and stop time were recorded by the assessor. Start and
stop times were subsequently input to a bespoke MATLAB
program that automatically segmented and analyzed the ac-
celerometer data. Digital synchronization to identify exact steps
(left/right steps) between systems was not used due to the short
distance traversed and lack of gyroscope within the BWM. How-
ever, the variability and asymmetry equations adopted in this
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Fig. 2. Identification of stride, stance, and swing times from the double support
phase of the IC and FC algorithm.
study accounted for all steps to be used interchangeably (see
Section II-E2).
D. Protocol and Data Collection
Participants were asked to walk at their preferred speed, per-
forming four intermittent straight line walking trials over 10.0 m.
The 7.0-m instrumented walkway was placed in the center of the
10.0 m (see Fig. 1) to ensure that gait was captured at a steady
speed. In addition, synchronized video of frontal plane mo-
tion was recorded during each walk. PD participants who were
on medication were tested approximately 1 h after medication
intake.
E. Data Analysis
1) BWM (Accelerometer) Data Processing: The BWM data
were downloaded to a computer, segmented into the four differ-
ent straight line passes using time stamps and analyzed by the
MATLAB program. Accelerometer signals were transformed to
a horizontal–vertical coordinate system [36], and filtered with a
fouth-order Butterworth filter at 20 Hz [12], [14] using the MAT-
LAB functions: detrend, butter, and filtfilt. For the purposes of
this study, the program utilized the novel application of a com-
bination of gait algorithms that have been previously developed
for a single sensor attached to L5 on a cohort of healthy older
adults.
a) Gait algorithm #1: The first algorithm estimated the IC
and FC events within the gait cycle (see Fig. 2), and is described
in detail elsewhere [12]. In brief, the algorithm consisted of the
following:
1) The IC and FC events are estimated from a continuous
wavelet transform (CWT, using the cwt MATLAB func-
tion) of av which was first integrated (cumtrapz) and then
differentiated using a Gaussian CWT; the IC events were
detected as the local minima of the CWT (findpeaks) [see
Fig. 3(a)]. A further differentiation resulted in the local
maxima being defined as the FC events [see Figs. 3(a)
and 4].
Previously, the algorithm has been used to estimate step and
stride times only [12]. However, in order to fully replicate the
Fig. 3. Flowchart of MATLAB analysis: Algorithm #1 (a), algorithm #2 (b),
and algorithm #3 (step velocity).
Fig. 4. Example of ICs (squares) and FCs (circles) detection during a single
pass on the walkway. The black solid line represents av , the dashed line the
differentiated with Gaussian CWT of av (av d ), and the dotted line the differen-
tiated with Gaussian CWT of av d (av dd ). Panel (a) shows the IC/FC algorithm
with spuriously detected IC events (circled squares). Panel (b) shows the correct
detection of the ICs and FCs with the optimized technique.
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core characteristics of gait, we needed to derive stance and
swing time. This was achieved through the sequence of IC and
FC events in relation to the double support phase of the gait
cycle (see Fig. 2). From the sequence (i) of IC and FC events,
both left and right (opposite) events were identified where stride
and subsequently stance and swing time were estimated (see
(1)–(3)). For direct comparison to the steps quantified by the
instrumented walkway, the initial and final four steps (walk
to/from the walkway) of the accelerometer data (as determined
by the IC/FC algorithm) were excluded from analysis
Stance time = FC (i + 1)− IC(i) (1)
Stride time = IC (i + 2)− IC(i) (2)
Swing Time = Stride time− Stance time. (3)
b) Gait algorithm #1: Optimization: Upon initial inspec-
tion of the signal traces, spurious IC events [i.e., non-IC events,
see Fig. 4(a)] were detected in 37% and 58% of the HC and PD
groups, respectively. As a result, the algorithm to detect IC and
FC events was refined to include a previous methodology for
improved step detection: The updated algorithm only included
IC peaks within a predetermined timed interval similar to Najafi
et al. [17]. The optimization procedure required IC events to
be identified during a predefined interval (0.25–2.25 s) from a
previous IC event. Fig. 4(b) shows an example of the updated
algorithm with the correct estimation of IC and FC events.
c) Gait algorithm #2: The second gait algorithm esti-
mated step length using the inverted pendulum model described
by Zijlstra and Hof [14] [see(4), Fig. 3(b)], where h represents
the change in height (vertical position) of the center of mass
(CoM) derived using the double integration (cumtrapz) of av
and l is the pendulum length (sensor height from ground)
Step Length = 2
√
2lh− h2 . (4)
d) Gait algorithm #2: Optimization: We evaluated the
step length using two methods: 1) l is estimated using leg length
× correction factor [14], and 2) l is estimated from the height of
the BWM located at L5, i.e., the ratio of the participants’ height
(l = height × 0.53) [37]. Preliminary analysis revealed better
agreement between systems for the second method compared
with using the correction factor and as a result was adopted in
this study.
e) Gait algorithm #3: To estimate a value for step veloc-
ity, we utilized algorithm #1 and #2 and the simple ratio between
distance (length) and time
Step Velocity = Step Length/Step Time. (5)
We replicated 14/16 [27] clinically relevant gait characteris-
tics (step width and step-width variability could not be measured
due to the adoption of a single triaxial accelerometer). The mean,
variability, and asymmetry values of the gait characteristics were
then calculated for direct comparison to gait characteristics de-
termined by the instrumented walkway (see following section
for details). Right and left IC’s were previously identified by the
sign of the filtered vertical angular velocity at the instant of IC
with the use of a gyroscope [12]. In this study, right and left IC’s
in the accelerometer signal were automatically selected from
the MATLAB program consistently assigning right steps to the
first detected step and alternating with left step assignment.
2) Laboratory Reference: Instrumented Walkway: Data for
individual steps for each walk were extracted from the instru-
mented walkway database using Microsoft Access 2007 (Mi-
crosoft Corp., Redmond, WA, USA). Mean gait values were
calculated for step time, stance time (duration the stance foot
was in contact with the ground for a given stride), swing time
(duration a foot was not in contact with the ground for a given
stride), step length, and step velocity. To calculate step variabil-
ity, the standard deviation (SD) from all steps (left and right
combined) was calculated (see (6)). SD was selected as a mea-
sure of variability due to its robustness and dual use with both
the BWM and walkway. Other measures of variability (har-
monic ratio, coefficient of variation) have been suggested but
have shown low to moderate agreement between systems [23],
[24], [38], [39] and are not all quantifiable by an instrumented
walkway.
We considered each walking pass separately, and as a result,
right and left steps were interchangeable. This method has no
impact on the evaluation of variability values, which were de-
scribed as the SD of all steps within walking trials (see (6)).
Asymmetry was determined as the absolute difference between
left and right steps (alternating) for each walking pass, averaged
across all passes (see (7)). As asymmetry represents the absolute
mean difference between right and left steps, it does not depend
on the detection of the “true” right and left steps
Variability = SD (Steps) (6)
Asymmetry = |AverageLeft − AverageRight| . (7)
F. Statistical Analysis
Statistical analysis was carried out using SPSS v19 (IBM).
Descriptive statistics (means and SD) were calculated for all
gait characteristics, in PD and HC pooled across the four passes.
Normality of data was tested with a Shapiro–Wilk test. Bland–
Altman plots were used to visually check for nonlinear or het-
eroscedastic distributions of error between the two systems (in-
strumented walkway versus BWM) as a function of the partici-
pants’ mean gait performance.
Absolute agreement between the two systems was formally
tested using intraclass correlation coefficients (ICC2,1) and lim-
its of agreement (LoA) expressed both as absolute values and
as a percentage of the mean. Relative agreement between the
two systems was also established using Pearson’s correlations
(r). Independent t-tests were used to examine the difference be-
tween groups for demographical data and systems’ outcomes (p
value <0.05 was considered as significant).
III. RESULTS
A. Demographic Data
Participants’ demographic, clinical, and cognitive descriptors
are shown in Table I. Compared to HC, PD participants were
aged matched; included proportionally less women (CL: 50%,
PD: 33%), presented with lower confidence in their balance
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TABLE I
CLINICAL AND DEMOGRAPHIC CHARACTERISTICS
Characteristic HC (n = 30)
Mean ± SD
PD (n = 30)
Mean ± SD
p
M/F (n) 15/15 20/10 0.197
Age (years) 66.6 ± 7.7 66.9 ± 9.4 0.891
Height (m) 1.7 ± 0.1 1.7 ± 0.1 0.795
BMI (Kg/m2) 28.0 ± 4.6 28.7 ± 5.4 0.585
MoCA (0–30) 27.9 ± 1.7 24.7 ± 3.1 <0.001
ABCs (0–100%) 91.3 ± 12.7 81.7 ± 20.0 0.031
Hoehn and Yahr
(n)
- HY I— 8 -
HY II—20
HY III—2
Levodopa
Equivalent Daily
Dose (mg/day)
- 163.3 ± 137.2 -
HYI − 137 ±
112.9
HYII − 177 ±
153.1
HYIII −
130 ± 14.1
MDS-UPDRS
III
- 29.5 ± 10.7 -
HYI − 17.5 ±
5.7
HYII − 32.9 ±
8.2
HYIII −
43.5 ± 3.5
Motor
Phenotype (n)
- PIGD 10 -
ID 4
TD 16
BMI: Body mass index; MoCA: Montreal cognitive assessment; ABC: Activities
specific balance confidence scale; UPDRS: Unified Parkinson’s disease rating
scale; PIGD: Postural instability and gait disorder phenotype; ID: Indeterminate
phenotype; TD: Tremor dominant phenotype. p difference between HC and people
with PD.
(ABCs), and poorer cognition (MoCA). No differences were
found between HC and PD participants for both height and BMI.
Participants with PD were in the early stages of the disease with
mild motor symptoms.
B. BWM and Instrumented Walkway: Agreement
Table II shows the agreement between the two systems for
ICC, r values and LoA (%). There was an excellent agree-
ment between the systems for all the mean gait variables (step
velocity, step time, stance time, and step length) except for
swing time. In contrast, asymmetry of steps (bilateral coordi-
nation) and variability (step to step fluctuations) showed poor
agreement.
Table III shows the results obtained from the derived gait pa-
rameters for both the BWM and instrumented walkway. Results
show that the BWM had systematic longer/greater gait charac-
teristics and this is significant for 10 of the 14 and 9 of the 14
variables for HC and PD, respectively.
1) BWM and Instrumented Walkway: Examination #1: To
explore the differences between systems for variability and
asymmetry, an analysis was conducted to check the potential
impact of the quality of the measured filtered acceleration av on
the differences observed. For exploratory purposes, we decided
to examine the step-time variability obtained by both systems.
TABLE II
AGREEMENT BETWEEN INSTRUMENTED WALKWAY AND BWM
Variable HC PD
ICC2 , 1 r LoA ICC2 , 1 r LoA
Mean gait characteristics
Step time (s) 0.983 0.998 1.2 0.981 0.997 1.4
Stance time (s) 0.927 0.912 9.5 0.913 0.854 1.4
Swing time (s) 0.766 0.708 18.0 0.511 0.618 19.5
Step length (m) 0.913 0.867 13.9 0.869 0.850 15.6
Step vel. (m/s) 0.952 0.906 14.7 0.928 0.890 16.7
Variability (var) gait characteristics
Step time var (s) 0.508 0.429 100.9 0.627 0.633 132.6
Stance time var (s) 0.645 0.747 159.9 0.529 0.576 164.2
Swing time var (s) 0.307 0.302 206.7 0.366 0.512 171.1
Step length var (m) 0.060 0.102 126.3 0.216 0.254 83.3
Step vel. var (m/s) –0.143 –0.086 110.2 0.225 0.229 107.5
Asymmetry (asy) gait characteristics
Step time asy (s) –0.637 –0.349 268.2 0.811 0.757 130.2
Stance time asy (s) 0.370 0.249 177.2 0.318 0.473 362.3
Swing time asy (s) –0.229 –0.111 316.1 0.448 0.304 259.7
Step length asy (m) 0.132 0.078 243.5 –0.223 –0.120 225.4
LoA expressed as a percentage (%) of the Mean; Step vel.: Step velocity.
A range of features based on the filtered av were calculated
and averaged across the four passes: mean, SD, root-mean-
square values (RMS), number of peaks (maxima of av ) and
valleys (minima of av ), number of zero crossing (ZC), and
frequency below which is the 95% of the signal power spectrum
(f95%). Pearson’s correlations explored the association between
each of these features and the differences in step-time variability
of the two systems. None of the extracted features showed a
strong positive correlation in either group (r < 0.353, Table IV),
demonstrating that the poor agreement for the variability results
could not be explained by the nature of the acceleration signal.
2) BWM and Instrumented Walkway: Examination #2: As
no correlations were found between av and the mean differences
between the systems, further analyses of the filtered av signal,
estimated step times, and instrumented walkway data were car-
ried out to explore the source of discrepancy for asymmetry and
variability.
In first instance, we explored the impact of the height of
the participants on the evaluation of the gait characteristics.
Pearson’s correlations revealed that only the HC stance time
asymmetry (r = 0.435, p = 0.016) and the PD swing time vari-
ability (r = −0.362, p = 0.049) showed a poor correlation with
height. Subsequently, our analysis uncovered two key findings:
1) Inspection of the filtered signal confirmed that the BWM
identified each step, but with a greater range of step-time
values (see Figs. 5 and 6). This is accounted for higher
variability and low agreement; moreover, variability is
evaluated considering all the steps (left and right com-
bined).
2) Where gait was clearly asymmetrical (e.g., PD), asymme-
try results were comparable [see Fig 6(a)], while more
subtle asymmetric gait patterns (e.g., HC) were de-
tected by the BWM but not instrumented walkway [see
DEL DIN et al.: VALIDATION OF AN ACCELEROMETER TO QUANTIFY A COMPREHENSIVE BATTERY OF GAIT CHARACTERISTICS 843
TABLE III
MEAN ± SD VALUES AND MEAN DIFFERENCES OF 14 GAIT PARAMETERS EVALUATED WITH AN INSTRUMENTED WALKWAY AND BWM
Characteristic HC PD
Instrumented walkway BWM Mean Difference, % p Instrumented walkway BWM Mean Difference, % P
Mean gait characteristics
Step time (s) 0.554 ± 0.051 0.567 ± 0.054 0.013, 2.4% <0.001 0.543 ± 0.045 0.555 ± 0.047 0.012, 2.2% <0.001
Stance time (s) 0.715 ± 0.080 0.731 ± 0.062 0.016, 2.2% 0.018 0.706 ± 0.072 0.717 ± 0.063 0.011, 1.6% 0.119
Swing time (s) 0.393 ± 0.031 0.404 ± 0.051 0.011, 2.7% 0.116 0.380 ± 0.029 0.394 ± 0.044 0.014, 3.7% 0.052
Step length (m) 0.692 ± 0.094 0.718 ± 0.099 0.026, 3.7% 0.009 0.638 ± 0.100 0.681 ± 0.089 0.043, 6.7% <0.001
Step vel. (m/s) 1.266 ± 0.219 1.275 ± 0.220 0.009, 0.7% 0.606 1.187 ± 0.223 1.242 ± 0.218 0.055, 4.6% 0.007
Variability (var) gait characteristics
Step time var (s) 0.017 ± 0.008 0.024 ± 0.011 0.007, 32.8% 0.002 0.022 ± 0.012 0.031 ± 0.023 0.009, 41.8% 0.009
Stance time var (s) 0.022 ± 0.012 0.026 ± 0.015 0.005, 21.8% 0.039 0.023 ± 0.010 0.033 ± 0.022 0.011, 46.3% 0.003
Swing time var (s) 0.016 ± 0.009 0.027 ± 0.024 0.011, 66.3% 0.015 0.019 ± 0.007 0.031 ± 0.025 0.013, 65.9% 0.004
Step length var (m) 0.023 ± 0.007 0.043 ± 0.021 0.021, 92.6% <0.001 0.025 ± 0.008 0.040 ± 0.015 0.015, 57.6% <0.001
Step vel. var (m/s) 0.058 ± 0.017 0.043 ± 0.021 −0.015. 25.4% 0.008 0.062 ± 0.023 0.040 ± 0.015 −0.022, 35.8% <0.001
Asymmetry (asy) gait characteristics
Step-time asy (s) 0.010 ± 0.006 0.015 ± 0.014 0.005, 38.2% 0.151 0.023 ± 0.027 0.023 ± 0.044 −0.0001, 0.3% 0.990
Stance time asy (s) 0.020 ± 0.012 0.014 ± 0.013 −0.006, 30.9% 0.035 0.022 ± 0.009 0.023 ± 0.045 0.001, 6.9% 0.846
Swing time asy (s) 0.010 ± 0.010 0.013 ± 0.015 0.003, 29.7% 0.387 0.018 ± 0.016 0.019 ± 0.024 0.001, 4.8% 0.848
Step length asy (m) 0.022 ± 0.016 0.014 ± 0.017 −0.008, 37.8% 0.049 0.024 ± 0.017 0.014 ± 0.015 −0.010, 4.6% 0.023
Mean difference: BWM – Instrumented walkway; Step vel.: Step velocity.
TABLE IV
RESULTS BETWEEN av FEATURES AND DIFFERENCES BETWEEN
INSTRUMENTED WALKWAY AND BWM STEP VARIBILITY
Features HC PD
Mean ± SD r Mean ± SD r
Mean av −0.990 ± 0.067 0.094 −1.001 ± 0.037 <0.001
SD av 0.127 ± 0.050 0.353 0.166 ± 0.058 <0.001
RMS av 1.006 ± 0.067 0.003 1.026 ± 0.040 0.015
# of peaks 128 ± 42 0.095 162 ± 61 0.048
# of valleys 108 ± 29 <0.001 132 ± 39 0.077
ZC 131 ± 37 0.009 167 ± 57 0.042
f95% 10.660 ± 2.372 0.108 11.518 ± 2.269 0.003
RMS: Root-mean-square values; SD: Standard deviations; #: number; ZC: Zero
crossing; f95%: frequency below which is the 95% of the signal power spectrum.
Fig. 5. Step time and step-time variability (SD) evaluated with the instru-
mented walkway and the BWM for HC and PD participant. The BWM show
higher step-time variability for both (a) HC and (b) PD.
Fig. 6(b)]. This may explain the higher agreement for PD
participants’ asymmetry results compared to HC (step-
time asymmetry, Tables II and III): people with PD often
show a clear asymmetric gait pattern, while asymmetry is
not pronounced as a feature in HC. This was confirmed
in individual patient videos, which were used as a refer-
ence to identify subtle features of gait identified by expert
physiotherapists and biomechanists.
IV. DISCUSSION
This study replicated 14 core characteristics of gait from a
generic triaxial accelerometer-based movement monitor using
a novel combination of gait algorithms (BWM) to segment the
gait cycle into discrete events. It is the largest and most compre-
hensive evaluation to date, which incorporates the comparison
of pathological and nonpathological cohorts.
We compared the BWM results to a known laboratory refer-
ence (instrumented walkway, GaitRite) and were able to explain
the systematic differences between systems unresolved by pre-
vious research.
A. Mean Characteristics and Effect of Pathology
Excellent (ICCs > 0.900, LoA < 15.0%) agreement was
found for mean step time, stance time, step length, and step
velocity for HC (ICCs2,1  0.913) and for step time, stance
time, and step velocity for PD (ICCs  0.913), similar to other
studies [12], [15]. Good agreement (ICCs 0.751–0.899, LoA
> 15.0%) was found for swing time for HC (ICC2,1 = 0.766)
and step length for PD (ICCs2,1 = 0.869) similar to previous
findings [15]. In contrast, we only found moderate agreement
(ICCs 0.500–0.750) for swing time for PD (ICCs = 0.511).
The poorer agreement for mean swing time could be related
to the limitation of the FC/IC algorithm where swing time was
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Fig. 6. (a) Example of clear asymmetric gait pattern of a PD participant (regular alternating of higher and lower absolute peak values of the acceleration signal,
X) and (b) subtle asymmetric pattern of a HC (less regular alternating of higher and lower absolute peak values of the acceleration signal, Y). Each panel in (a) and
(b) displays (i) accelerometer sensor waveform and a zoomed example of four consecutive steps (red dots/arrows), (ii) corresponding data from the instrumented
walkway and a zoomed example of same four consecutive steps (red arrows), and (iii) mean results from the two systems for each example.
not accounted for in its design. Though the algorithm [12] eval-
uated IC and FC events, the authors presented step and stride
time values, which is based on the IC estimation only. However,
the detection of FCs allowed us to derive stance and swing time
with contrasting results for both. Moreover, error is inherently
assumed as swing time was computed in our study from the
difference between stride and stance time, where small inaccu-
racies may also exist. Swing time estimation may be improved
from direct IC and FC analysis rather than the method adopted
here based on the relationship between stance, swing, and stride
time within the gait cycle.
Good agreement was found for step length within the PD
group, while the HC had excellent agreement (ICC2,1 = 0.913),
similar to another study [15]. LoA for HC and PD were < 16.0%
and mean percentage differences were 3.7% for HC and 6.7%
for PD which equates to longer estimated distances of 0.026
and 0.043 m, respectively, which we consider acceptable [15].
Traditionally, high reproducibility has been problematic with
step length due to adoption of the inverted pendulum model on
which it is based [14], [40], [41]. The model assumes a com-
pass gait cycle (circular trajectory) [14], which is not the case in
an asymmetric disease (PD). Moreover, the model also assumes
straight line walking at a constant pace, which makes it problem-
atic when testing within pathology or during laboratory-based
protocols where continuous walking for better gait variability
estimation is the recommendation [42]. Thus, there is a need
to better refine step length estimation where the calculation of
vertical displacement (h), pendulum length (l), or the adoption
of a generic correction factor are sources of error.
Algorithms independent of site specific variables (h, l) and
correction factors will allow for more robust quantification of
step length. To date individualized correction factors have been
recommended for improved step length estimation rather than
generic or group specific values [18], [20]. However, these
would be time consuming and difficult to implement in day-to-
day clinical practice or in large-scale clinical/intervention-based
studies where instrumentation of gait is often time constraint
[43]. We were unable to calculate estimates for the remaining
core gait characteristics, i.e., step width and step-width vari-
ability due to the limitations of the BWM and adoption of a
single triaxial accelerometer. Moreover, step-width estimation
is yet to be determined from a single accelerometer-based BWM
due to the bipedal dynamics of human locomotion and relative
mediolateral placement of feet.
B. Variability and Asymmetry Characteristics
and Effect of Pathology
We found poor to moderate agreement between systems for
all variability and asymmetry characteristics, similar to previous
studies [23], [24], [38], [39], [44]. Therefore, we conducted an
analysis to explore the lack of agreement to offer new insight into
gait quantification with these systems. We hypothesized that the
corrupt features of the filtered acceleration signal would impact
the error between systems. However, there were no significant
correlations in any of the extracted features, verifying that the
standard filtering procedure (fourth-order Butterworth, cut off
20 Hz) and resulting signal were robust. Further exploration of
all the filtered acceleration signals together with all participant
videos highlighted subtle asymmetries in gait that were only
evident in the BWM signal and not in instrumented walkway. A
number of possible explanations account for these differences:
1) We found that height of the participants had an impact
on the error of the estimation of stance time asymmetry
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and swing time variability, and this can be related to the
limitation of the FC/IC algorithm.
Asymmetry was more comparable between instruments
for PD because it is a more prominent feature of patholog-
ical gait. Asymmetry in HC is subtle and more difficult to
detect with an instrumented walkway due to slight varia-
tions in dynamics of the CoM rather than discrete footfalls.
These results have impact on variability which were not
comparable. Greater asymmetry increases the estimation
of variability for accelerometry, given its sensitivity to
detecting this feature of gait.
2) An instrumented walkway detects footfalls but an
accelerometer-based BWM continuously tracks the po-
sition of the body resulting in a continuous signal (see
Figs. 4 and 6). The resulting peak, therefore, represents
the trajectory of the CoM rather than actually heel strike
(IC) or toe-off (FC) events determined by an instrumented
walkway.
3) Gait algorithms are dependent on the signal characteristics
(e.g., peaks reliant on polynomial coefficients or local
maxima to locate the maximum of a peak). Thus, delay
in the location of the maximum/minimum due to peak
detection methods or smoothness of peak as a result of
filtering or processing can introduce timing differences
between the BWM signal and instrumented walkway to
a resolution required for variability/asymmetric outcomes
(ms).
C. Instrumented Walkway: Functionality and Sources of Error
The instrumented walkway used in this study (GaitRite) has
been previously shown to be a reliable method for measuring
mean gait characteristics [45], but less so for asymmetry and
variability [23], [24], [38], [39]. Another plausible explanation
for these discrepancies is the operational functionality of the
walkway itself. Specifically, the walkway is an array of pressure
sensors that activate or trigger a footfall event when a load is
applied. These events usually occur as a collective to define
the entire surface area of the foot and subsequently IC and FC
events. However, spurious contacts may result due to scuffing
or a shuffling walk introducing false IC events. As a result, the
technician/researcher can review the series of contacts (activated
pressure sensors) for each footfall and subjectively include or
exclude an individual sensor (within the array defining a foot) if
they deem it suitable during a walk. With a spatial accuracy of
1.27 cm, this (subjective) inclusion/exclusion of sensors can be
the difference of approximately 0.009 s based on an estimated
stepping speed (step velocity 142 cm/s). With variability and
asymmetry quantified at a similar resolution (see Table III), the
inclusion/exclusion of a single pressure sensor in the walkway
can be a further source of disagreement between systems.
D. Alternative Laboratory Reference
Previous work has used continuous tracking of the CoM with
a 3-D motion analysis system [21], [46], [47]. Direct compar-
ison of vertical acceleration, velocity, and position (displace-
ment) traces together with spatial-temporal parameters showed
good agreement between the optical motion capture system and
an inertial measurement unit (BWM) [21], [46]. Despite good
agreement, the comparison of an accelerometer-based BWM
to a 3-D system, though more similar in quantification of gait,
measure different components: acceleration and displacement,
respectively. Though acceleration and displacement can be re-
lated through single and double integration/derivation, that pro-
cess introduces error through drift, where the error in the signal
after each integration increases by ε = t1.5 , where t is the inte-
gration time and ε is the error [21], [48].
Therefore, systematic errors will always remain between sys-
tems (instrumented walkway versus accelerometer-based BWM
on the lower back (L5) versus 3-D motion analysis system)
even when measuring-related components explaining why in
our study there is a lower agreement for the mean swing time,
higher variability of step time (see Fig. 6), and estimation of
(subtle) symmetry differences. This, however, does not infer
that one system is less valid, rather that both systems are valid
but differences can be explained by different methodological
approaches used to estimate gait events.
BWM tend to have greater estimates for gait characteristics
(a feature of the adopted algorithms), but was systematic in its
nature and the values remained within expected ranges for both
PD and HC. Importantly, pathology did not influence our find-
ings, although this may change with increased disease severity
and gait impairment.
E. Study Limitations and Future Work
This study achieved its aims of quantifying 14-core gait char-
acteristics, while also deriving a new rationale to account for
poor agreement between a BWM (worn at L5) and an in-
strumented walkway. However, some limitations do exist and,
therefore, we make recommendations for future research. For
instance, the methodology presented has been tested in a labo-
ratory environment, considering walking at self-selected speed
on a group of healthy participants and those with PD. There-
fore, before being able to generalize our results in these groups,
further analysis would be required to test the robustness of the
combination of algorithms across different gait speeds.
Moreover, our PD group had mild motor symptoms and more
severe motor symptoms may influence the gait pattern and algo-
rithm performance. For instance, the lack of clearly identifiable
signal characteristics (peaks/troughs) within the filtered signal
may result in the miss or no detection of IC/FC events. While
we included a range of PD participants (PIGD, ID, TD), there
was no major (visually observant) limitation within their gait,
such as shuffling.
The addition of a gyroscope sensor within the BWM would
allow the complete quantification of the 16 gait characteristics
identified as important [27], [28]. Additionally, the extra sensor
would allow the correct identification and allocation of left/right
steps. The improved step recognition methodology would allow
the variance of left and right steps to be calculated separately
and then be combined to find SD (see (8)). This method avoids
confounding step-to-step variability with variation originating
from asymmetry between left and right steps [42]. Moreover,
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the correct identification of each left/right step could then be
directly compared between systems
SDleft or right=
√
(Varianceleft + Varianceright)
2
. (8)
V. CONCLUSION
A simple triaxial accelerometer device is able to replicate
14 clinically relevant core gait characteristics. Agreement with
a laboratory reference system ranged from excellent (mean)
to poor (variability and asymmetry), which we interpreted as
primarily an intrinsic limitation of the comparison between two
systems which measure different properties: continuous motion
(BWM) versus single footfall events (instrumented walkway).
Despite this, we feel confident from our results that a single
triaxial accelerometer-based BWM is accurate for measuring
gait variability and asymmetry.
Accelerometer-based BWM may offer advantages over stan-
dard laboratory systems for selected characteristics, potentially
making them a more sensitive device to detect any subtle
changes in gait pattern due to ageing and/or pathology. When
compared to an instrumented walkway, systematically greater
values of mean gait characteristics need to be taken into consid-
eration. However, a system currently does not exist which cap-
tures a broad range of gait outcomes sensitive to early pathology,
is low-cost (<£100), and capable of being deployed in multi-
center large-scale studies for instrumented testing or within the
community for real-world continuous data collection. This ap-
proach (use of a generic movement monitor and algorithms
from the literature) may, therefore, offer a low-cost solution
for quantitative gait evaluation in PD and HC during instru-
mented testing and in a wide variety of environments (including
at home). Further work is going on to optimize gait quantifica-
tion algorithms as well as to explore step-width estimation and
the impact of algorithm sensitivity on disease progression and
disease severity.
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